Press enter or spacebar to select a desired language.
Press enter or spacebar to select a desired language.
Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

2561 - 2570 of 3824 results found

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update from the American College of Physicians

MeSH Terms

Hemoglobin A; Glycosylated (D12.776.422.316.762.380.440); Hemoglobin A; Glycosylated (D12.776.124.400.405.440); Hemoglobin A; Glycosylated (D09.408.375); Diabetes Mellitus; Type 2 (C19.246.300); Therapeutic Uses (D27.505.954); Metformin (D02.078.370.141.450); Thiazolidinediones (D02.886.675.933); Dipeptidyl Peptidase 4 (D23.050.301.264.035.283); Diabetes Mellitus (C19.246); Drug Therapy; Combination (E02.319.310); Dipeptidyl-Peptidase IV Inhibitors (D27.505.696.422.500); Sodium-Glucose Transporter 2 (D12.776.157.530.500.750.750); Sodium-Glucose Transporter 2 (D12.776.543.585.500.750.750); Dipeptidyl-Peptidase IV Inhibitors (D27.505.519.389.745.335)

Guideline Contact
Amir Qaseem ([email protected])
Publication Date
01/03/2017
Date of Last Evidence Search
12/2015
Methods Applied
See Publication
Publication Scope
Treatment
Countries of Application
United States
Guideline Publication Status
Inactive
Languages
English
Authors
ACP (US)
Publication Year
2017
My Saved Lists